Form4insider filings, from the source

SEC Form 4 · accession 0001193805-15-001798

ALIMERA SCIENCES INC · ALIM

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
DEERFIELD MANAGEMENT CO
10% Owner · Other
Deerfield Mgmt L.P.
10% Owner · Other
James E Flynn
10% Owner · Other
Deerfield Mgmt III, L.P.
10% Owner · Other
Period of report
Oct 27, 2015
Accepted (ET)
Oct 29, 2015 · 6:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001267602

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F3,F4Oct 27, 2015P16,506$3.00A4,444,597IThrough Deerfield Special Situations Fund, L.P.
Common StockF1,F3,F4Oct 27, 2015P16,506$3.00A412,906IThrough Deerfield Private Design Fund III, L.P.
Common StockF2,F3,F4Oct 28, 2015P13,165$2.99A4,457,762IThrough Deerfield Special Situations Fund, L.P.
Common StockF2,F3,F4Oct 28, 2015P13,165$2.99A426,071IThrough Deerfield Private Design Fund III, L.P.
Common StockF3,F4holding———181,222IThrough Deerfield Private Design Fund II, L.P.
Common StockF3,F4holding———207,667IThrough Deerfield Private Design International II, L.P.

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses

Remarks

Jonathan Isler, Attorney-in-Fact: Power of Attorney, which is hereby incorporated by reference to Exhibit 24 to a Form 3 with regard to Avalanche Biotechnologies, Inc. filed with the Securities and Exchange Commission on July 30, 2014 by Deerfield Mgmt III, L.P., Deerfield Mgmt, L.P., Deerfield Management Company, L.P., Deerfield Special Situations Fund, L.P., Deerfield Special Situations International Master Fund, L.P., Deerfield Private Design Fund III, L.P. and James E. Flynn